Cases & Deals

Baxter Ventures invests in Calabash Bioscience

Clients Baxter International Inc.

Jones Day advised Baxter Ventures in connection with its investment in Calabash Bioscience, Inc., a start up cancer diagnostics and therapeutics company which was born out of Harvard University's Wyss Institute.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.